National Institute of Allergy and Infectious Diseases

KEYWORD SEARCH

Apply

Lower Dose of Mpox Vaccine Is Safe and Generates Six-Week Antibody Response Equivalent to Standard Regimen

April 29, 2024

Study Highlights Need for Defined Markers of Mpox Immunity to Inform Public Health Use

Subscribe to National Institute of Allergy and Infectious Diseases